Ryan Lafferty (@RA_Lafferty) header
Ryan Lafferty (@RA_Lafferty) profile picture

Ryan Lafferty

@RA_Lafferty

PhD | MPharm | CEO @ Dia Beta Labs Ltd | RT not an endorsement | Views are my own (even the good ones) |

 Belfast
diabetalabs.com/
Joined June 2020
  • Tweets73
  • Following262
  • Followers41
17Media
Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)Photo by Ryan Lafferty (@RA_Lafferty)
Delighted to have been in attendance at this event this morning on behalf of Dia Beta Labs! The innovative start-up community in NI is truly exciting and we are thrilled to be a part of it! #Startups #Innovation #NorthernIreland
Ulster University (@UlsterUni) profile pictureUlster University@UlsterUni25 Oct 2023
It was brilliant to be able to talk to the delegation about our developments in partnership. The business leaders were impressed by our collaborations with regional partners for investments exceeding £2 billion through the City and Growth Deals. #OurGiantAmbition
Image from Ulster University (@UlsterUni)
62
Ryan Lafferty retweeted
Novo Nordisk (@novonordisk) profile picture
Novo Nordisk
@novonordisk8 Aug 2023
#PRESS Novo Nordisk product reduces the risk of major adverse cardiovascular events by 20% in adults with overweight or obesity in trial

9
55
17
194
80,358
Dia Beta Labs are an @UlsterUni spin-out company treating diabetes disease progression. Read the @IrishTimes article where CEO @RA_Lafferty explains more about this research, and the potential to cure diabetes: irishtimes.com/special-repor… Visit the website: diabetalabs.com/

Taking a holistic approach to diabetes treatment

Ulster University spin-out company Dia Beta Labs is engaged in the development of a number of therapeutic peptides which have the potential to transform the lives of type 2 diabetes sufferers around...

irishtimes.com
1
1
4
662
New Year, new me? No, New Year, new website! Delighted to announce our new and improved Dia Beta Labs website is now live! Check it out at diabetalabs.com #Diabetes #Research
1
61
Our latest article on the benefits of glucagon receptor antagonism is now #OpenAccess Check it out below 👇 #Research #Diabetes
Journal of Endocrinology (@JEndocrinology) profile pictureJournal of Endocrinology@JEndocrinology22 Nov 2022
Read this research article by Ryan A Lafferty et al. titled 'Sustained glucagon receptor antagonism in insulin-deficient high-fat-fed mice' @UlsterUni @RA_Lafferty #Diabetes #Glucagon #Insulin Read the full article #openaccess: doi.org/10.1530/JOE-22-0106
Image from Journal of Endocrinology (@JEndocrinology)
👀
Diabetes UK (@DiabetesUK) profile pictureDiabetes UK@DiabetesUK17 Nov 2022
📢 BREAKING NEWS: The world’s first ever immunotherapy for #Type1Diabetes has been approved in the US. It’s the biggest breakthrough for the condition since the discovery of insulin 100 years ago. Read more about this milestone moment in T1 history: diabetes.org.uk/about_us/new… (1/3)
Infographic reads: 'Breaking news: The world's first ever immunotherapy drug for type 1 diabetes has been approved in the US.'

ALT Infographic reads: 'Breaking news: The world's first ever immunotherapy drug for type 1 diabetes has been approved in the US.'

Many thanks to @hiranihealth for featuring the exciting work of Dia Beta Labs in light of #WorldDiabetesDay! Find out more at diabetalabs.com! #Diabetes #DiabetesDay #Research #Innovation
HIRANI (@hiranihealth) profile pictureHIRANI@hiranihealth14 Nov 2022
Today is #WorldDiabetesDay2022 and we have some excellent research and innovation in place for diabetes in Northern Ireland. Check out some of our companies and researchers here: lnkd.in/eEU2jirA @JoannRhode5 @vascversa @QUBelfast @UlsterUni @HSC_NI @HSCQI @healthdpt
🎉🎉🎉 A great performance, huge congratulations to all involved!
Ulster University (@UlsterUni) profile pictureUlster University@UlsterUni12 May 2022
📣International experts have judged Ulster University in the top 10% of UK Universities for research impact (4*/3*). We’re changing lives around our region and around the world. View the press release & impact case studies🔽 ulster.ac.uk/news/2022/may/u… #REFResults #ProudofUU
Put that #MondayMotivation to good use and apply for one of the PhD opportunities currently available at the Diabetes Research Group @UlsterUni ! Application deadline is next Monday, 28th of Feb! 👉 bit.ly/3H6IC5h #PhD #AcademicTwitter #Opportunity
Image from Ryan Lafferty (@RA_Lafferty)
Pleased to be sharing our dedicated Dia Beta Labs website with you all! Why not learn more about our spinout, our team and our research platforms in one convenient place? 👉 diabetalabs.com/ #DrugDevelopment #DrugDiscovery #Obesity #Diabetes #LifeSciences
1
1
There is still plenty of time to participate in this short #survey! All feedback is invaluable to us! #DrugDiscovery #Research #AcademicChatter #LifeSciences #Obesity #Diabetes 👇👇
Ryan Lafferty (@RA_Lafferty) profile pictureRyan Lafferty@RA_Lafferty6 Aug 2021
Are you an academic involved in #obesity or #diabetes related #preclinical work? We are seeking opinions on what drives academia to outsource in this field via the following 2 min survey 👉 bit.ly/3BIZBt1 #DrugDiscovery #AcademicTwitter #LifeSciences
1
Still plenty of time to contribute to this anonymous #survey! We would love to hear your views! #DrugDiscovery #LifeSciences #Research #AcademicChatter #Diabetes #Obesity 👇👇
Ryan Lafferty (@RA_Lafferty) profile pictureRyan Lafferty@RA_Lafferty6 Aug 2021
We are seeking opinions on what drives #pharma, #biotech & #startup companies to outsource #preclinical work in #obesity and #diabetes related research via the following 2 min survey 👉 bit.ly/3eZw5oS #DrugDiscovery #AcademicTwitter #LifeSciences
There is still time to contribute to this anonymous #survey! We would love to hear your views! #healthcareWorkers #DiabetesNetwork #DiabetesNetworkNI 👇👇
Ryan Lafferty (@RA_Lafferty) profile pictureRyan Lafferty@RA_Lafferty6 Aug 2021
Calling all HCP's working with #diabetes & #obesity patients! We are seeking opinions on current prescribing options & on future therapeutic directions We would greatly appreciate participation in this 2 min survey! bit.ly/3kT8ryg #DiabetesNetwork #DiabetesNetworkNI
News: our @UlsterUniBiomed Research Institute launches expanded, world class facilities, with a new state-of-the-art lab & equipment, boosting expert research already taking place at Coleraine including nutrition, diabetes, vision science, pharmaceutical science and genomics:
1
18
1
46
We are seeking opinions on what drives #pharma, #biotech & #startup companies to outsource #preclinical work in #obesity and #diabetes related research via the following 2 min survey 👉 bit.ly/3eZw5oS #DrugDiscovery #AcademicTwitter #LifeSciences
1
1
1
Are you an academic involved in #obesity or #diabetes related #preclinical work? We are seeking opinions on what drives academia to outsource in this field via the following 2 min survey 👉 bit.ly/3BIZBt1 #DrugDiscovery #AcademicTwitter #LifeSciences
1
1
1
Calling all HCP's working with #diabetes & #obesity patients! We are seeking opinions on current prescribing options & on future therapeutic directions We would greatly appreciate participation in this 2 min survey! bit.ly/3kT8ryg #DiabetesNetwork #DiabetesNetworkNI
1
Start off your #fridaymorning right! This review explores current evidence on how sex and ethnicity influence #CVD in #diabetes 👉 bit.ly/3inLx07 🔓 #Endocrinology #AcademicTwitter #FOAMed
Image from Open Access Endocrinology (@OpenAccess_Endo)
2
2
Congratulations to @UlsterHealthSci's Prof. Finbarr O'Harte, who is among the top 10% most cited @PLOSONE papers published in 2018! Read the article 👉 bit.ly/3ihKA9A 🔓 #PLOSTopCited #AcademicTwitter #Diabetes
Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves...

Long-term treatment with acylated analogues of apelin-13 amide ameliorates diabetes and improves...

Previous studies have shown that modified apelin analogues exhibited enzyme resistance in plasma and improved circulating half-life compared to apelin-13. This study investigated the antidiabetic...

journals.plos.org
Image from Ryan Lafferty (@RA_Lafferty)
1
Pleased to be sharing details of our NewCo, Dia Beta Labs, currently enrolled on the ICURe market discovery programme to investigate our potential to spin-out from @UlsterUni See our flyer 👉 bit.ly/3AHqyg8 #Exciting #Diabetes #Obesity #Research
Dia Beta Labs Flyer | Ryan Lafferty

Dia Beta Labs Flyer | Ryan Lafferty

Pleased to share our flyer for Dia Beta Labs, a NewCo from the Diabetes Research Group @ Ulster University. We are currently enrolled on the ICURe market discovery programme, gauging interest in our...

linkedin.com
1
Load more